Mednet Logo

What is your approach to severe discoid lupus refractory to conventional topical and systemic therapies?

(Refractory to mycophenolate, azathioprine, and methotrexate. UpToDate suggests thalidomide or IVIG with mixed efficacy, while there are some case reports of tofacitinib use or leflunomide.)
Community PollStarted

What targeted therapy have you found most helpful in treating severe refractory discoid lupus?

67 physicians have voted

Join Mednetto vote and see how they answered.

5 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · NYU Langone Health
Answered on

Agree with Dr. @Dr. First Last's comprehensive answer regarding the treatment of refractory DLE. However, would add two biological options, Belilumab and anifrolumab. In fact, just now evaluated with a fellow a patient in Lupus clinic with refractory DLE to intralesional steroids, Chloroquine after ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Dermatology · Feinberg School of Medicine
Answered on

In management of discoid lupus (DLE), first line therapies include topical corticosteroids, topical calcineurin inhibitors, and antimalarial therapy with hydroxychloroquine. Injected corticosteroids can be helpful for hyperkeratotic lesions and particularly for lesions affecting the scalp. If there ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · NYU Langone Health
Answered on · Updated on

Below is a slide I present to fellows regarding the treatment of DLE, including many off-label options and some with minimal data. Dapsone is most effective for neutrophilic dermatosis which in CLE is mostly bullous lupus whereas ACLE, SCLE, and DLE are more lymphocytic. Moreover, although for HCQ a...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · Medical University of South Carolina
Answered on

Absolutely agree with Dr. @Dr. First Last. We are having excellent responses in skin with anifrolumab, even in severe refractory disease. We have just published a case report of our first such success; she remains off steroids since 2 weeks after starting anifrolumab last year.

Shope et al., JAAD 20...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Rheumatology · University of Chicago
Answered on

I have had excellent results with a 6-month or so course of lenalidomide. One of my patients not only has quiet discoid but is repigmenting her skin! She has been off for 2 years and continues to have skin pigment recovery.

Join for free or sign in to see the full answer